Sorrento Therapeutics, Inc. (SRNE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 809.01M |
| Enterprise value | 787.24M |
| Trailing P/E | N/A |
| Forward P/E | 1.10 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 11.27 |
| Price/book (mrq) | 3.57 |
| Enterprise value/revenue | 13.80 |
| Enterprise value/EBITDA | -1.64 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.43 |
| 52-week change 3 | -79.77% |
| S&P500 52-week change 3 | -11.08% |
| 52-week high 3 | 11.0700 |
| 52-week low 3 | 1.1500 |
| 50-day moving average 3 | 1.6474 |
| 200-day moving average 3 | 4.0234 |
Share statistics
| Avg vol (3-month) 3 | 10.17M |
| Avg vol (10-day) 3 | 17.4M |
| Shares outstanding 5 | 388.95M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 358.91M |
| % held by insiders 1 | 5.79% |
| % held by institutions 1 | 33.60% |
| Shares short (30 May 2022) 4 | 54.08M |
| Short ratio (30 May 2022) 4 | 6 |
| Short % of float (30 May 2022) 4 | 14.07% |
| Short % of shares outstanding (30 May 2022) 4 | 13.90% |
| Shares short (prior month 28 Apr 2022) 4 | 54.66M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:25 |
| Last split date 3 | 31 July 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -679.18% |
Management effectiveness
| Return on assets (ttm) | -32.96% |
| Return on equity (ttm) | -206.57% |
Income statement
| Revenue (ttm) | 57.03M |
| Revenue per share (ttm) | 0.19 |
| Quarterly revenue growth (yoy) | 29.00% |
| Gross profit (ttm) | -167.05M |
| EBITDA | -374.52M |
| Net income avi to common (ttm) | -471.65M |
| Diluted EPS (ttm) | -1.5270 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 270.66M |
| Total cash per share (mrq) | 0.71 |
| Total debt (mrq) | 248.88M |
| Total debt/equity (mrq) | 110.03 |
| Current ratio (mrq) | 1.62 |
| Book value per share (mrq) | 0.62 |
Cash flow statement
| Operating cash flow (ttm) | -317.12M |
| Levered free cash flow (ttm) | -160.27M |
© 2022 Yahoo. All rights reserved.
